Research Hub
Psychedelic research, tracked.
A living, evidence-informed index of 2026 psychedelic research and registered trials, drawn from PubMed and ClinicalTrials.gov. Filter by substance, focus, study type or source, sort it however you read, and share or cite any slice in seconds.
PubMed ClinicalTrials.gov
742 entries627 studies115 trialsIndex last checked 21 September 2026
How this index is built
- Sources
- PubMed (peer-reviewed literature) and ClinicalTrials.gov (registered trials).
- Scope
- Research from 2026 onward relating to psychedelic-assisted therapy and psychedelic medicine.
- Included
- Studies and trials on efficacy, safety, mechanism, practice, ethics, regulation and access for psilocybin, MDMA, ketamine, LSD, DMT, ayahuasca, ibogaine and related compounds.
- Not yet included
- Preprints, non-English-language records, grey literature, and other trial registries such as ANZCTR and the EU Clinical Trials Register.
- Refresh
- Rebuilt automatically each week.
- Stance
- Automated inclusion is not endorsement. Entries are listed for information only and are not clinical or treatment advice.
Filters
Jurisdiction
Substance
Focus
Study type
Source
Trial status
Information only. Inclusion is not endorsement or clinical advice. Open any entry to read the original source.
Research results
No entries match those filters.
This index is compiled automatically from PubMed and ClinicalTrials.gov and refreshed weekly. Inclusion is not endorsement and is provided for information only; it is not clinical or treatment advice. Always read the original source.
